Hydroxyzin Bluefish

Hydroxyzine Dihydrochloride, the active ingredient in Hydroxyzin Bluefish, is a first‑generation antihistamine presented as an oral formulation for oral use. It is used to relieve itching, anxiety, and nausea in adult patients. GNH USA supplies Hydroxyzin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Dihydrochloride is indicated for conditions mediated by histamine release and central nervous system activity. - Allergic dermatitis: reduces itching and inflammation associated with skin allergic reactions. - Pruritus: alleviates generalized itching caused by various dermatologic disorders. - Anxiety: provides short‑term relief of anxiety symptoms. - Sedation: induces calming effects useful before procedures. - Nausea: helps control nausea and vomiting related to motion or medication.

Hydroxyzine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a parched sensation. - Blurred vision: temporary difficulty focusing. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Tachycardia: rapid heart rate that may require medical attention. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting. - Anaphylaxis: rare allergic reaction with swelling, breathing difficulty, and rash.

Before prescribing Hydroxyzin Bluefish, clinicians should consider several safety factors. - Pregnancy: limited data; use only if potential benefit justifies potential risk. - Breastfeeding: may be excreted in milk; assess risk versus benefit. - Elderly patients: increased sensitivity to sedative effects; start with lower doses. - Driving or operating machinery: may impair alertness; advise caution. - Concomitant CNS depressants: monitor for additive sedation. - Store at room temperature: keep in original container, protect from moisture and light.

Hydroxyzine can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and syncope. - CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression. - Anticholinergic agents: heightened anticholinergic burden leading to confusion or urinary retention.

Moderate Interactions (Monitor Closely): - Other antihistamines: increased drowsiness. - Alcohol: enhances sedative effects. - CYP3A4 inhibitors (e.g., erythromycin): may raise hydroxyzine plasma concentrations.